IRCT20090117001556N107招募中3 期
Sulforaphane treatment of autism spectrum disorder: a double blind controlled trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 years 至 12 years（—）
- 性别
- All
入选标准
- •DSM-5 clinical diagnosis of autistic disorder
- •Children between the ages of 3 and 12 years old
- •Presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
排除标准
- •Presence of any active medical problem
- •Other psychiatric diagnosis except for mild to moderate Intellectual disability
- •Receiving any antipsychotic medications during past monthprior to the trial
- •Severe hepatic disease
- •History of allergy to risperidone and intolerance of it
- •History of seizure requiring change of antiepileptic dose during the last month
- •Seizure during the last 6 months
研究者
相似试验
已完成
1 期
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)Autism Spectrum DisorderNCT02561481University of Massachusetts, Worcester60
进行中（未招募）
2 期
Sulforaphane in a New Jersey (NJ) Population of Individuals With AutismAutistic DisorderAutistic BehaviorAutismAutism Spectrum DisorderNCT02677051Rutgers, The State University of New Jersey48
招募中
不适用
Improving independence in driving for people with Autism Spectrum DisorderNeurological - Other neurological disordersMental Health - Autistic spectrum disordersAutism Spectrum DisorderACTRN12616001151426Hoe Lee60
招募中
2 期
Sulforaphane for the treatment of ADHDIRCT20090117001556N146Tehran University of Medical Sciences50
招募中
不适用
Schema therapy for adults with autism and personality disorderschema therapy, adults, autism spectrum disorder, personality disorder, cognitive-behavioral, experientialschematherapie, volwassenen, autismespectrumstoornis, persoonlijkheidsstoornis, cognitief gedragstherapeutisch, experientieelNL-OMON28080Sarr expertise centre for autism (part of Parnassia group)Oudedijk 763062 AG RotterdamThe Netherlands12